In the last trading session, 129.12 million Senti Biosciences Inc (NASDAQ:SNTI) shares changed hands as the company’s beta touched 2.70. With the company’s per share price at $10.00 changed hands at $7.84 or 362.96% during last session, the market valuation stood at $46.31M. SNTI’s last price was a premium, traded about 25.7% off its 52-week high of $7.43. The share price had its 52-week low at $1.52, which suggests the last value was 84.8% up since then. When we look at Senti Biosciences Inc’s average trading volume, we note the 10-day average is 10050.0 shares, with the 3-month average coming to 17.91K.
Senti Biosciences Inc (NASDAQ:SNTI) trade information
Instantly SNTI was in green as seen at the end of in last trading. With action 360.70%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 51.52%, with the 5-day performance at 360.70% in the green. However, in the 30-day time frame, Senti Biosciences Inc (NASDAQ:SNTI) is 360.83% up. Looking at the short shares, we see there were 65095.0 shares sold at short interest cover period of 3.27 days.
Senti Biosciences Inc (SNTI) estimates and forecasts
Data shows that the Senti Biosciences Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 233.78% over the past 6 months, a 49.04% in annual growth rate that is considerably higher than the industry average of 17.70%.
The 2024 estimates are for Senti Biosciences Inc earnings to increase by 40.12%, but the outlook for the next 5-year period is at 17.99% per year.
SNTI Dividends
Senti Biosciences Inc is expected to release its next quarterly earnings report in January.
Senti Biosciences Inc (NASDAQ:SNTI)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 21.00% of Senti Biosciences Inc shares while 23.33% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 29.53%. There are 23.33% institutions holding the Senti Biosciences Inc stock share, with NEA MANAGEMENT COMPANY, LLC the top institutional holder. As of 2024-06-30, the company held 9.6834% of the shares, roughly 4.43 million SNTI shares worth $1.22 million.
8VC GP I, LLC holds the second largest percentage of outstanding shares, with 5.5516% or 2.54 million shares worth $7.0 million as of 2024-06-30.
